Endothelins and their receptors in cirrhotic and neoplastic livers of Canadian and Chinese populations

Anticancer Research

Volumn 19, Issue 3 B, 1999, Pages 2243-2247

  Cai, L ^a,b   Wang, G J ^b   Mukherjee, K ^a   Xu, Z L ^b   Khalil, M ^a   Cherian, M G ^a   Chakrabarti, Subrata ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b JILIN UNIVERSITY   (China)

Author keywords

Cirrhosis; Endothelin receptor; Endothelin 1; Endothelin 3; Fibrolamellar carcinoma; Hepatocellular carcinoma; Liver

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN RECEPTOR; POLYCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; CANADA; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LIGAND BINDING; LIVER CARCINOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER METASTASIS; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM;

ADENOCARCINOMA; AUTORADIOGRAPHY; CANADA; CARCINOMA, HEPATOCELLULAR; CHINA; COLONIC NEOPLASMS; ENDOTHELIN-1; ENDOTHELIN-3; HUMANS; IODINE RADIOISOTOPES; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; RECEPTORS, ENDOTHELIN; REFERENCE VALUES; RETROSPECTIVE STUDIES;

EID: 0032780617     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Highsmith, RF: Endothelin, Molecular Biology, Physiology, and Pathology. Humana Press, Totowa, 1998.
2. Eakes A and Olson MS: Regulation of endothelin synthesis in hepatic endothelial cells. Am J Physiol 274: G1068-G1076, 1998.
3. Gulati A: Endothelin: Role in Health and Disease. Harwood Academic Publishers, Australia. 1995.
4. Moller S and Henriksen JH: Endothelins in chronic liver diseases. Scand J Clin Lab Invest 56: 481-90, 1996.
5. Gandhi CR, Sproat LA and Subbotin VM. Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic rats. Life Sci 55: 55-62, 1996.
6. Patel K. and Schrey MP: Endothelins in breast cancer. In: Mammary Tumor Cell Cycle, Differentiation and Metastasis, (Dickson R and Lippman M. eds), Boston, Kluwer Academic Publishers. 1996, pp 269-394.
7. Asham EH, Loizidou M and Taylor I: Endothelin-1 and tumour development. Eur J Surg Oncol 24: 57-60, 1998.
8. Gerbes AL, Moller S, Gulberg V and Henriksen JH: Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function. Hepatology 21: 735-739, 1995.
9. Pinzani M, Milani S, De Franco R, Grappone C, Caligiuri A, Gentilini A, Tosti-Guerra C, Maggi M and Failli P, Ruocco C and Gentilini P: Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activate hepatic stellate cells. Gastroenterology 110: 534-548, 1996.
10. Rockey DC, Fouassier L, Chung JJ, Carayon A, Vallee P, Rey C and Housset C: Cellular localization of endothelin-1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on Stellate cells. Hepatology 27: 472-480, 1998.
11. Yamashita J, Ogawa M, Inada K, Yamashita S, Matsuo S and Takano S: A large amount of endothelin-1 is present in human breast cancer tissues. Res Comm Chem Pathol Pharmacol 74: 363-369, 1991.
12. Pekonen F, Nyman T, Ammala M and Rutanen E-M: Decreased expression of messenger RNAs encoding endothelin receptors and neutral endopeptidase 24.11 in endometrial cancer. Br J Cancer 71: 59-63, 1995.
13. Inagaki H, Bishop AE, Eimoto T and Polak JM: Autoradiographic localization of endothelin-1 binding sites in human colonic cancer tissue. J Pathol 168: 263-267, 1992.
14. Watanabe K, Hiraki H, Hasegawa H, Tanigawa T, Emura I, Honma K, Shibuya, H Fukuda T and Suzuki T: Immunohistochemical localization of endothelin-1, endothelin-3 and endothelin receptors in human pheochromocytoma and paraganglioma. Pathol Int 47: 540-546, 1997.
15. Ishibashi M, Fujita M, Nagai K, Kako M, Furue H, Haku E, Osamura Y and Yamaji T: Production and secretion of endothelin by hepatocelluar carcinoma. J Clin Endocrinol Metal 161: 562-567, 1993
16. Nakamuta M, Ohashi M, Tabata S, Tanabe Y, Goto K, Naruse M, Naruse K, Hiroshige K and Nawata H: High plasma concentrations of endothelin-like immunoreactivities in patients with hepatocellular carcinoma. Am J Gastroenterol 88: 248-52, 1993.
17. Kar S, Yousem SA and Carr BI: Endothelin-1 expression by human hepatocellular carcinoma. Biochem Biophys Res Commun 216: 514-519, 1995.
18. Miyauchi T, Suzuki N, Kurihara T, Yamaguchi I, Sugishita Y, Matsumoto H, Goto K and Masaki T: Endothelin-1 and endothelin-3 play different roles in acute and chronic alterations of blood pressure in patients with chronic hemodialysis. Biochem Biophys Res Commun 178: 276-281, 1991.
19. Wolf SC, Smoltczyk H, Brehm BR, Erley CM and Risler T: Endothelin-1 and endothelin-3 levels in different types of glomerulonephritis. J Cardivasc Pharmacol 31 (Suppl. 1): 482-485, 1998.
20. Helal T, Bassin M and Khalifa A: Immunohistochemical markers of tumor prognosis in breast cancer in Egypt. Cancer Detect Prev 21: 201-206, 1997.
21. Chakrabarti S and Sima AAF: Endothelin-1 and endothelin-3-like immunoreactivity in the eyes of diabetic and non-diabetic BB/W rats. Diabetes Res Clin Pract 37: 109-20, 1997.
22. Moore D, Ohene-Fianko D, Garcia B and Chakrabarti S: Apoptosis in thyroid neoplasms: relationship with p53 and bcl-2 expression. Histopathology 32: 35-42, 1998.
23. Chakrabarti S, Ghahary A, Murphy LJ and Sima AAF: Insulin-like growth factor-I expression is not increased in the retina of diabetic BB/W-rats. Diabetes Res Clin Pract 14: 91-98, 1991.
24. Stitt AW, Chakravarthy U, Gardiner TA and Archer DB: Endothelinlike immunoreactivity and receptor binding in the choroid and retina. Curr Eye Res 15: 111-117, 1995.
25. Shankar A, Loizidou M, Aliew G, Fredericks S, Holt D, Boulos PB, Burnstock G and Taylor I: Raised endothelin 1 levels in patients with colorectal liver metastases. Br J Surg 85: 502-506, 1998.
26. Alanen K, Deng DX and Chakrabarti S: Endothelin-1 and Endothelin-3 and their receptors in normal and neoplastic breast tissue. Lab Invest 78 (Suppl.) 16A, 1998.